Beneficient (BENF) Cash & Equivalents (2022 - 2026)

Beneficient (BENF) has 5 years of Cash & Equivalents data on file, last reported at $2.5 million in Q1 2026.

• For the quarter ending Q1 2026, Cash & Equivalents rose 85.74% year-over-year to $2.5 million; the trailing twelve-month figure through Mar 2026 stood at $2.5 million (up 85.74% YoY), and the FY2026 full-year result was $2.5 million, up 85.74% from the prior year.
• Cash & Equivalents eased to $2.5 million in Q1 2026, from $7.9 million in the prior quarter.
• In the past five years, Cash & Equivalents ranged from a high of $70.6 million in Q1 2022 to a low of $1.3 million in Q1 2025.
• A 5-year average of $10.1 million and a median of $4.7 million in 2024 frame the typical range for Cash & Equivalents.
• Across the five-year window, Cash & Equivalents tumbled 87.64% in 2023 and jumped 92.68% in 2025, its largest moves.
• Tracing BENF's Cash & Equivalents over 5 years: stood at $70.6 million in 2022, then tumbled by 84.13% to $11.2 million in 2023, then slumped by 63.39% to $4.1 million in 2024, then jumped by 92.68% to $7.9 million in 2025, then plunged by 68.35% to $2.5 million in 2026.
• Business Quant data shows BENF's Cash & Equivalents at $2.5 million in Q1 2026, $7.9 million in Q4 2025, and $4.9 million in Q3 2025.